Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients

This study has been completed.
Sponsor:
Collaborator:
Cangene Corporation
Information provided by (Responsible Party):
Georgetown University
ClinicalTrials.gov Identifier:
NCT00998426
First received: October 7, 2009
Last updated: March 21, 2014
Last verified: June 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)